A New Multi-Marker Test for Preventing Ovarian Cancer

The Roma test combines two serologic biomarkers, human-epiditimous protein-4 and cancer antigen 125. The potential benefit of this test is that it might help with pre-surgical planning in a patient with an ovarian mass. However, there's a major concern about the limitations of how the Roma test has been studied.